商品名(trade name) | |
藥理作用(Pharmacological Effects) | [partial agonist [[antagonist: Endometrial, breast [[agonist: inhibit osteoclast formation |
用量與用法(Dosage and Usage) | |
適應症(Indications) | {osteoporosis {incidence of breast cancer {reduce total cholesterol and LDL cholesterol |
副作用(Side effect) | |
禁忌/交互作用(Contraindications / interaction) |
Saturday, October 12, 2013
raloxifene
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment